[The program ALTERNATIVA--investigation of antianginal efficacy and tolerability of coraxan (ivabradine) and assessment of quality of life of patients with stable angina: results of an epidemiological stage].
Karpov
Iu A
IuA
Deev
A D
AD
D000787:Angina Pectoris / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D001552:Benzazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D000077550:Ivabradine; D008297:Male; D008875:Middle Aged; D009017:Morbidity / Q000639:trends; D011788:Quality of Life; D012189:Retrospective Studies; D012426:Russia / Q000453:epidemiology; D013237:Stereoisomerism; D016896:Treatment Outcome
D001552:Benzazepines; D000077550:Ivabradine